Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

National Waste Management Holdings, Inc. (NWMH) Announces 269% Revenue Growth for Third Quarter

Before the opening bell, National Waste Management Holdings, Inc. (OTC: NWMH) announced its financial results for the three months ended September 30, 2016. Notably, the company achieved year-over-year revenue growth of 269 percent, recording $1.7 million in total revenue for the quarter. National Waste recorded similar growth for the first nine months of 2016, with […]

Singlepoint, Inc. (SING) CEO Reflects on Impact of Election Day Results on MoneyTV with Donald Baillargeon

Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” The show includes informative interviews with company CEOs, offering prospective investors insight into their operations and outlooks for […]

Trevena, Inc. (TRVN) is “One to Watch”

Trevena, Inc. (NASDAQ: TRVN) is a clinical stage biopharmaceutical company focused on developing and delivering biased ligands to discover the next generation of GPCR targeted medicine. The company is focused on three product candidates: Oliceridine, for moderate to severe acute pain; TRV734, an oral use medicine for people in moderate, severe acute, and chronic pain; […]

Celldex Therapeutics, Inc. (CLDX) is “One to Watch”

Last month, Celldex Therapeutics, Inc. (NASDAQ: CLDX), a company in the business of developing targeted therapeutics for those suffering from devastating diseases for which current treatments are inadequate, found positive results from its phase II study of glembatumumab vedotin in patients with stage III/IV checkpoint inhibitor-refractory. The study showed that patients experienced a confirmed response, […]

Medical Transcription Billing, Corp. (MTBC) Announces Third Quarter Results

Before the opening bell, Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) announced its financial and operational results for the third quarter of 2016, including a review of the October acquisition of MediGain, LLC and subsidiary Millennium Practice Management, LLC, which was the company’s largest acquisition to date. Notably, MTBC’s revenues for the three-month period were […]

 

From Our Blog

From Tokenization to Production: MindWave Innovations Inc. (NYSE American: APUS) Positions MindChain for the Next Phase of Real-World Assets

August 12, 2026

For years, the promise of blockchain in financial markets centered on putting traditional assets on chain. Now, the harder question is emerging: what infrastructure is needed to make those assets useful on an institutional scale? Tokenized real-world assets, or RWAs, are beginning to move beyond experimentation. Tokenized Treasury funds, private credit products, commodities and other […]

Rotate your device 90° to view site.